— Know what they know.
Not Investment Advice

CTIC NASDAQ

CTI BioPharma Corp.
1W: +0.2% 1M: +1.1% 3M: +111.4% 1Y: +52.3% 3Y: +615.8% 5Y: +80.7%
$9.10
Last traded 2023-06-23 — delisted
NASDAQ · Healthcare · Biotechnology · $1.2B mcap · 100M float · 6.36% daily turnover

Balance Sheet Trends

Total Assets
$126M +73.8% ▲
5Y CAGR: +18.1%
Total Liabilities
$144M +109.0% ▲
5Y CAGR: +29.9%
Shareholders Equity
-$18M -566.6% ▼
Cash & Investments
$80M +22.1% ▲
5Y CAGR: +24.0%
Total Debt
$50M -1.2% ▼
5Y CAGR: +28.9%
Net Debt
$20M +231.2% ▲

Assets vs Liabilities & Equity

Year-over-Year Growth

View Full Balance Sheet
Line ItemFY2018FY2019FY2020FY2021FY2022
— Assets —
Cash$36M$31M$40M$65M$30M
Short-Term Investments$31M$3M$12M$0$50M
Cash & ST Investments$67M$34M$52M$65M$80M
Net Receivables$0$0$0$0$15M
Inventory$0$0$0$0$733K
Other Current Assets$15M$2M$2M$3M$3M
Total Current Assets$82M$36M$54M$68M$99M
Property, Plant & Equip.$2M$5M$3M$3M$2M
Goodwill & Intangibles$0$0$0$0$23M
Long-Term Investments$0$0$0$0$0
Other Non-Current Assets$6M$6M$1M$770K$1M
Total Non-Current Assets$7M$11M$4M$4M$27M
Total Assets$90M$46M$58M$72M$126M
— Liabilities —
Accounts Payable$4M$0$2M$4M$2M
Short-Term Debt$5M$5M$4M$49M$48M
Deferred Revenue$0$0$7M$14M$0
Other Current Liabilities$14M$14M$11M$14M$31M
Total Current Liabilities$23M$18M$17M$67M$81M
Long-Term Debt$9M$7M$800K$2M$0
Other Non-Current Liab.$5M$2M$374K$0$62M
Total Non-Current Liabilities$14M$10M$1M$2M$62M
Total Liabilities$37M$28M$18M$69M$144M
— Equity —
Common Stock$58K$58K$76K$0$131K
Retained Earnings-$2.2B-$2.3B-$2.3B-$2.4B-$2.5B
Accumulated OCI-$11M-$12M$2K$0-$35K
Total Stockholders Equity$59M$18M$40M$4M-$18M
Total Liabilities & Equity$90M$46M$58M$72M$126M
— Key Metrics —
Total Debt$14M$12M$5M$51M$50M
Net Debt-$22M-$19M-$35M-$15M$20M
Total Investments$31M$3M$12M$0$50M

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms